Business
Notice of Results and Investor Presentation
Notice of Results and Investor Presentation.
About this update from Venture Life Group Plc
[{"type":"text","content":"\n\n4 April 2024\n \nVENTURE LIFE GROUP PLC\n(\"Venture Life\", \"VLG\" or the \"Group\")\nNotice of Results\nand\nInvestor Presentation via Investor Meet Company\n \nVenture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the self-care market confirms that it will release its results for the year ended 31 December 2023 on 9 April 2024.\nThe Company also announces that Jerry Randall (CEO) and Daniel Wells (CFO) will provide a live presentation relating to the 2023 Full Year Results via Investor Meet Company on 11 Apr 2024, 14:30 BST.\nThe presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9:00am the day before the meeting or at any time during the live presentation.\nInvestors can sign up to Investor Meet Company for free and add to meet Venture Life Group plc via:\nhttps://www.investormeetcompany.com/venture-life-group-plc/register-investor\nInvestors who already follow Venture Life Group plc on the Investor Meet Company platform will automatically be invited.\n \nFor further information, please contact:\n \n\n\n\n\nVenture Life Group PLC\n\n\n+44 (0) 1344 578004\n\n\n\n\nJerry Randall, Chief Executive Officer\nDaniel Wells, Chief Financial Officer\n\n\n\n\n\n\n\n \nCavendish Capital Markets Limited (Nomad and Broker)\n\n\n \n+44 (0) 20 7720 0500\n\n\n\n\nStephen Keys/Camilla Hume (Corporate Finance)\nMichael Johnson (Sales)\n\n\n \n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbout Venture Life (www.venture-life.com)\nVenture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, Italy, The Netherlands and Sweden, the Group's product portfolio includes some key products such as the Balance Active range in the area of women's intimate healthcare, the Earol® product line in ENT care, the Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, the UltraDEX and Dentyl oral care product ranges, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. Its products are sold in over 90 countries worl...